Kenvue, Inc. leadership unpacked plans on 23 February that will reveal “a very different Kenvue” in 2024 compared with 2023, which marked its separation from Johnson & Johnson and launch as a standalone public company.
‘The Problem Is In-Store’: Kenvue CEO Mongon Lays Out Plan To Kickstart Skin Health & Beauty
The J&J spinout and Neutrogena and Aveeno owner says the challenge facing its Skin Health and Beauty business is not about brand equity or online performance as much as in-store in the US, where it has underperformed. CEO Thibaut Mongon outlined planned investments, expected to drive growth acceleration in Kenvue’s fiscal 2024 second half, at the CAGNY 2024 conference.
